Article

Seroconversion of a city: Longitudinal monitoring of SARS-CoV-2 seroprevalence in New York City

2020-06-29

Abstract excerpt

By conducting a retrospective, cross-sectional analysis of SARS-CoV-2 seroprevalence in a ‘sentinel group’ (enriched for SARS-CoV-2 infections) and a ‘screening group’ (representative of the general population) using >5,000 plasma samples from patients at Mount Sinai Hospital in New York City (NYC), we identified seropositive samples as early as in the week ending February 23, 2020. A stark increase in seropositiv...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 34459e6a-7730-522c-8f3f-2df465ae0f97
DOI: 10.1101/2020.06.28.20142190

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Seroconversion of a city: Longitudinal monitoring of SARS-CoV-2 seroprevalence in New York CityDOI 10.1101/2020.06.28.20142190Read

SARS-CoV-2 dynamics in New York City during March 2020–August 2023Semantic proximity Read

Changing epidemiology of SARS-CoV-2 positivity rates in a diverse population of children and adults during variant evolution and progressive vaccination eligibility in New York CitySemantic proximity Read

Estimated SARS-CoV-2 Antibody Seroprevalence and Infection to Case Ratio Trends in 50 States and District of Columbia, United States—October 25, 2020, to February 26, 2022Semantic proximity Read

SARS-CoV-2 Seroprevalence Studies: A Rapid ReviewSemantic proximity Read

Community prevalence of SARS-CoV-2 in England during April to September 2020: Results from the ONS Coronavirus Infection SurveySemantic proximity Read

Prevalence of IgG Antibodies to SARS-CoV-2 in Wuhan – Implications for the Longevity of Antibodies Against SARS-CoV-2Semantic proximity Read

The Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland (Study protocol)Semantic proximity Read

First “snap-shot” meta-analysis to estimate the prevalence of serum antibodies to SARS-CoV-2 in humansSemantic proximity Read

Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysisSemantic proximity Read

Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adultsSemantic proximity Read

The prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-upSemantic proximity Read

Reduced Odds of SARS-CoV-2 Reinfection after Vaccination among New York City Adults, June–August 2021Semantic proximity Read